✦ LIBER ✦

Chemoembolization Is Effective as Second-Line Therapy in Patients with Colorectal Carcinoma Metastatic to the Liver

✍ Scribed by Romano Danesi; Antonello Di Paolo

Book ID: 119616948
Publisher: CIG Media Group, LP.
Year: 2002
Tongue: English
Weight: 55 KB
Volume: 2
Category: Article
ISSN: 1533-0028
DOI: 10.1016/s1533-0028(11)70325-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized Phase II Trial of Embolizatio

Randomized Phase II Trial of Embolization Therapy Versus Chemoembolization Therapy in Previously Treated Patients with Colorectal Carcinoma Metastatic to the Liver

✍ Huda S. Salman; Jacov Cynamon; Marci Jagust; Curtis Bakal; Alla Rozenblit; Ron K 📂 Article 📅 2002 🏛 CIG Media Group, LP. 🌐 English ⚖ 111 KB

Utility of embolization or chemoemboliza

Utility of embolization or chemoembolization as second-line treatment in patients with advanced or recurrent colorectal carcinoma

✍ Donald J. Martinelli; Scott Wadler; Curtis W. Bakal; Jacob Cynamon; Alla Rozenbl 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 854 KB

Utility of embolization or chemoemboliza

Utility of embolization or chemoembolization as second-line treatment in patients with advanced or recurrent colorectal carcinoma

✍ Camillo Porta; Mauro Moroni; Giuseppe Nastasi; Enrico Bobbio-Pallavicini; Gianca 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 344 KB 👁 1 views

The association of clinical outcome to f

The association of clinical outcome to first-line VEGF-targeted therapy with clinical outcome to second-line VEGF-targeted therapy in metastatic renal cell carcinoma patients

✍ Mhd Y. Al-Marrawi, Brian I. Rini, Lauren C. Harshman, Georg Bjarnason… 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 269 KB

An Open-label, Single-arm, Phase 2 Trial

An Open-label, Single-arm, Phase 2 Trial of Panitumumab Plus FOLFIRI as Second-line Therapy in Patients with Metastatic Colorectal Cancer

✍ Allen L. Cohn; Grace C. Shumaker; Pankaj Khandelwal; David A. Smith; Marcus A. N 📂 Article 📅 2011 🏛 CIG Media Group, LP. 🌐 English ⚖ 429 KB

New aromatase inhibitors as second-line

New aromatase inhibitors as second-line endocrine therapy in postmenopausal patients with metastatic breast carcinoma : A pooled analysis of the randomized trials

✍ Paolo Carlini; Emilio Bria; Diana Giannarelli; Gianluigi Ferretti; Alessandra Fe 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 224 KB 👁 2 views